Sketch of Lewis/Cleveland Clinic Foundation heart pump showing
placement.

Photo of Lewis/Cleveland Clinic Foundation heart pump.
Impeller blade design codes and flow-modeling analytical codes will be used in the project. These codes were developed at Lewis for the aerospace industry but will be applicable to the IVAS design project. The analytical codes, which currently simulate the flow through the compressor and pump systems, will be used to simulate the flow within the blood pump in the artificial heart assist device. The Interdisciplinary Technology Office heads up Lewis' efforts in the IVAS project. With the aid of numerical modeling, the blood pump will address many design issues, including some fluid-dynamic design considerations that are unique to the properties of blood. Some of the issues that will be addressed in the design process include hemolysis, deposition, recirculation, pump efficiency, rotor thrust balance, and bearing lubrication. Optimum pumping system performance will be achieved by modeling all the interactions between the pump components. The interactions can be multidisciplinary and, therefore, are influenced not only by the fluid dynamics of adjacent components but also by thermal and structural effects.
Lewis-developed flow-modeling codes to be used in the pump simulations will include a one-dimensional code (ref. 1) and an incompressible three-dimensional Navier-Stokes flow code (ref. 2). These codes will analyze the prototype pump designed by the Cleveland Clinic Foundation. With an improved understanding of the flow phenomena within the prototype pump, design changes to improve the performance of the pump system can be verified by computer prior to fabrication in order to reduce risks. The use of Lewis flow modeling codes during the design and development process will improve pump system performance and reduce the number of prototypes built in the development phase.
The first phase of the IVAS project is to fully develop the prototype in a laboratory environment that uses a water/glycerin mixture as the surrogate fluid to simulate blood. A later phase of the project will include testing in animals for final validation. Lewis will be involved in the IVAS project for 3 to 5 years.
Last updated April 26, 1996
Responsible NASA Official:
Gynelle.C.Steele@nasa.gov
216-433-8258
Point of contact for NASA Glenn's Research & Technology reports:
Cynthia.L.Dreibelbis@nasa.gov
216-433-2912
SGT, Inc.
Web page curator:
Nancy.L.Obryan@nasa.gov
216-433-5793
Wyle Information Systems, LLC